However, the role of renin–angiotensin–aldosterone system (RAAS) in the development of hypertension in OSA patients remains poorly defined, with inconclusive evidence regarding the activation of the RAAS in these patients. The gene discussed is REN; the disease is obstructive sleep apnea syndrome.